PTGX

PTGX Other Income/Expenses (Net)

$26.00MTTM · USD

Period ending:

PTGX FY Other Income/Expenses (Net)USD
PTGX FY Other Income/Expenses (Net)2014-12-31: -$1.75M2015-12-31: -$64.00K2016-12-31: -$4.51M2017-12-31: $940.00K2018-12-31: $2.55M2019-12-31: $2.64M2020-12-31: -$329.00K2021-12-31: $294.00K2022-12-31: $3.98M2023-12-31: $14.70M2024-12-31: $26.57M2025-12-31: $28.82M$28.82M-$4.51M
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PTGX other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Protagonist Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
28,816,000
26,565,000
14,697,000
3,980,000
294,000
-329,000
2,643,000
2,546,000
940,000
-4,511,000
-64,000
-1,753,000

Compare other income/expenses (net)

All PTGX financial metrics · PTGX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.